pharma.economictimes.indiatimes

Sun Pharma recalls topical anesthetic, anti-fungal cream in US

Sun Pharmaceutical Industries has initiated a voluntary recall of its lidocaine ointment and nystatin cream in the US after ...
pharma.economictimes.indiatimes

Indian CDMOs must build capability and trust, not just capacity, to win global innovation mandates: Experts

Discover how Indian CDMOs can evolve from cost-effective manufacturers to trusted collaborators in pharmaceutical innovation ...
pharma.economictimes.indiatimes

Pharma affordability must be designed upstream, not fixed at distribution stage: Industry leaders

Industry leaders emphasize the need for integrating affordability into R&D and product design rather than solely addressing ...
pharma.economictimes.indiatimesOpinion

India’s pharma story must move beyond generics to innovation: Suven’s Venkat Jasti

Venkateswarlu Jasti, Chairman & MD of Suven Life Sciences, discusses the future of India’s pharmaceutical industry and the ...
pharma.economictimes.indiatimes

Bilateral trade deals can open doors, but India’s pharma scale-up will depend on ecosystem depth

Explore how India's growing bilateral trade agreements can strengthen its pharmaceutical and medical device export ...
pharma.economictimes.indiatimes

Pharma supply chains need end-to-end quality oversight: CDSCO’s Dr K Narendran

Dr. K Narendran of CDSCO emphasizes the importance of maintaining quality in pharmaceutical supply chains from manufacturing to patient delivery. Key practices for ensuring quality include supplier ...
pharma.economictimes.indiatimes

India’s pharma, medtech resilience hinges on critical localisation, not complete self-reliance: Experts

Experts discuss the importance of critical localisation in India's pharmaceutical and medical device sectors, focusing on reducing dependence on imports and enhancing logistical and manufacturing ...
pharma.economictimes.indiatimes

China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion

InnoCare Pharma and Eli Lilly enter a landmark collaboration agreement valued at up to $3.35 billion to develop new cancer and autoimmune disease treatments, including $100 million upfront and $3.25 ...
pharma.economictimes.indiatimes

Wegovy pill may be best GLP-1 option to tackle recent weight gain

Early analysis reveals Novo Nordisk's Wegovy pill may be the most effective GLP-1 option for individuals struggling with ...
pharma.economictimes.indiatimes

Pharma Supply Chains in Flux: Navigating Tariffs, Trade and Geopolitics

Explore the evolving landscape of India's pharmaceutical supply chains, addressing the pressing challenges of reliance on ...
pharma.economictimes.indiatimes

Roche signs drug-discovery deal with Atavistik Bio worth up to $2 billion

Atavistik Bio has signed a significant agreement with Roche to develop oral treatments for cardiovascular, kidney, and ...
pharma.economictimes.indiatimes

Alkem CFO Nitin Agrawal steps down

New Delhi: Mumbai-based Alkem Laboratories Chief Financial Officer (CFO), has resigned from his post to pursue new professional opportunities. In an intimation to the stock exchanges, the company ...